Independent Non-Executive Chairman
Mr Greg Hutchinson
Greg has held leadership roles in rapidly scaling clinical services delivery for over 30 years, spending the last 13 as the CEO of Sonic HealthPlus and Deputy CEO of Sonic Clinical Services, subsidiaries of Sonic Healthcare Limited (ASX: SHL) an S&P/ASX 100 company. Having graduated with First Class Honours in Physiotherapy (Bachelor of Applied Science) in 1989, Greg went on to establish a successful chain of private physiotherapy clinics throughout Australia. In the process, he completed Post Graduate studies in Sports Physiotherapy and enjoyed professional appointments with a variety of professional sporting clubs, events and teams.
Professor Sir John Tooke
Sir John has 30 years’ experience as a consultant physician. He is Chair of Collaboration for the Advancement of Sustainable Medical Innovation (CASMI) UCL and chaired oversight on the Academy of Medical Sciences project ‘How we best use scientific evidence to judge the benefits and harms of medicines’. Sir John is a Non-Executive Director of BUPA Chile and chairs the Medical Advisory Council.
Dr Karen Smith
Dr Smith is a Biotech/Pharmaceutical Executive, Board Director and Clinical/Scientific Advisor in the US, Europe, Canada and Asia. Her breadth of experience covers over 100 clinical trials and 20+ major regulatory approvals in multiple jurisdictions, including FDA (USA), EMA (Europe), TGA (Australia), ANVISA (Brazil), and PMDA (Japan); leading to product launches across diverse therapeutic areas including areas in oncology, rare disease, cardiology, dermatology, neuroscience, and anti-infectives. In addition to R&D and pipeline development, Dr Smith’s successful record of business development includes acquisitions, divestitures, and partnership deals.
Dr Alistair Vickery
Alistair is a specialist medical practitioner with over 30 years’ experience. Prior to Emyria, Alistair was an Associate Professor of Primary Health Care at the University of Western Australia and Deputy Chair of the Postgraduate Medical Council of WA.
Dr Mohit Kaushal
Dr. Mohit Kaushal is a healthcare tech entrepreneur and investor, serving as an advisor at General Atlantic LLC and on the board of five other companies. With a focus on mental health, he has held notable positions at Humedica, Rxante, and Change Healthcare, as well as having been involved in healthcare initiatives during the Obama administration and collaborating with the FDA at the Federal Communications Commission.
CEO & Managing Director
Dr Michael Winlo
Michael has extensive experience in leading high-growth teams. Prior to Emyria, he served as CEO of Linear Clinical Research and, before that, lived in Silicon Valley where he worked for Palantir, helping major healthcare institutions in the US and UK solve complex data integration and analysis challenges. Michael is a medical doctor with an MBA from Stanford.
Chief Operating Officer
Mary-Ann has over 14 years’ experience across the Pharmaceutical, Oil and Gas and Professional Services Industries in Australia and Norway. She has worked in both commercial and operational roles, with a strong focus on contract management and negotiation. Prior to starting at Emyria, Mary-Ann was Head of Business Development at a Pharmaceutical Manufacturing Company. Mary-Ann is passionate about healthcare and working in a company that has a focus on meeting patients unmet needs.
Head of Preclinical Drug Development
Tatjana Heinrich is a highly experienced Group Lead in Preclinical Drug Development with a strong background in Biotechnology. Her expertise lies in Drug Discovery, Project Management, Molecular Biology, Peptide Chemistry, Protein Expression, and Bioinformatics. She holds a PhD in Biochemistry and Molecular Biology from Freie Universität Berlin, showcasing her dedication to advancing this field. Tatjana’s leadership skills and vast experience in this critical domain drive Emyria’s innovative research and development to improve patient outcomes.
Head of Research & Drug Development
Tracie has worked in patient care and research for over 15 years. Starting her career as an oncology registered nurse in Canada, she went on to earn degrees in public health and health management, and has spent the last 10 years managing cancer clinical trials in Australia. She is passionate about designing investigator-driven research that shapes patient care and improves the patient experience.
Chief Financial Officer
Joseph has over 30 years’ experience in the accounting field, has been a finance director of private companies and CFO, Company Secretary and Director of ASX listed companies. Joseph has over 10 years’ experience in the biotech industry and has an MBA in International Business.
Clinical Systems Manager
Margaret has over 25 years of experience in managing medical clinics and professionals in Australia. Margaret was the owner and director of a northern suburbs general practice, managing over 20 staff. She is a surveyor with AGPAL for the accreditation of general practice medical centres Australia-wide.
Dr Wayne Aston
Wayne has been working in the Medical and Research sectors for 7 years. Wayne has a PhD in cancer immunology. He has successfully completed courses in entrepreneurship and digital health innovation. He is an alumni of the Perth BioDesign program and is passionate about accelerating the use of digital healthcare technologies to improve the circumstances of others.
Adrienne has over a decade of experience coordinating complex projects and tenders across a range of industries and helping individuals and organisations visualise – and improve – their processes. Prior to joining Emyria, she worked in various process improvement roles at Linear Clinical Research, and before that, she worked as a bid manager, travelling around the country to help the likes of PwC, Spotless, and G4S win new business.
Chemistry, Manufacturing & Controls Lead
Claudia is a Chemistry, Manufacturing, and Controls Lead who has dedicated her extensive career to the pharmaceutical industry. With close to a decade of experience in Pharmaceutical Manufacturing and in a Phase One clinical trials unit, Claudia has honed her expertise in clinical research and pharmaceutical product manufacturing. She excels in managing Quality Control, Quality Assurance, Quality Systems, Regulatory and Compliance, all while maintaining stringent Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) standards.
Head of Clinical Operations
An accomplished leader, Catherine Smith has dedicated over a decade to advancing health and medical research. She has honed her expertise through clinical trial coordination, ethics, and governance roles, working closely with international pharmaceutical firms to establish studies in Australia. Catherine’s most recent position involved overseeing research operations at Emyria, driven by a profound commitment to delivering innovative therapies to patients.
Our Clinical Ambassadors, lead by Professor Sir John Tooke, are nationally and internationally recognised as experts in their field. Their expertise includes drug discovery, formulation and registration, clinical trials, psychiatry and treatment of mental health disorders, research, learning health systems, data analysis, pain management and much more.
Our ambassadors play a vital role supporting our vision to accelerate the development and registration of new drugs and care models. The resulting new treatments can transform the lives of millions of people around the world living with conditions for which current therapies are either ineffective, cause unwanted side effects or are yet to be created.
Professor Sir John Tooke
Dr Jennifer Morgan
Dr Morgan is an anaesthetist and pain specialist. She established the first private pain services at St John of God Hospital and Hollywood Hospital in Western Australia. Her interests include the prevention of acute pain developing into chronic pain and chronic pain conditions, such as neuropathic pain.
Dr Philip Finch
Dr Finch is an anaesthetist and pain specialist with over 40 years of experience. He is the Medical Director of the Perth Pain Management Centre in WA and has a specialist interest in interventions using nerve blocks and radiofrequency lesioning in a number of spinal and other structures. He is also interested in the field of neuropathic pain, specifically complex regional pain.